Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer

Author:

Antonelli Luca12,Ardizzone Davide3,Tachibana Isamu4ORCID,Adra Nabil5ORCID,Cary Clint4ORCID,Hugar Lee6,Sexton Wade J.6ORCID,Bagrodia Aditya78ORCID,Mego Michal9,Daneshmand Siamak10ORCID,Nicolai Nicola11,Nazzani Sebastiano11ORCID,Giannatempo Patrizia11,Franza Andrea11ORCID,Heidenreich Axel1213ORCID,Paffenholz Pia12,Saoud Ragheed14ORCID,Eggener Scott14ORCID,Ho Matthew14,Oswald Nathaniel15,Olson Kathleen15,Tryakin Alexey16ORCID,Fedyanin Mikhail16ORCID,Naoun Natacha17,Javaud Christophe17,Cazzaniga Walter18ORCID,Nicol David1819,Gerdtsson Axel2021ORCID,Tandstad Torgrim2223,Fizazi Karim17ORCID,Fankhauser Christian Daniel1324ORCID,

Affiliation:

1. Department of Urology, Luzerner Kantonsspital, University of Lucerne, Lucerne, Switzerland

2. Department of Urology, Policlinico Umberto I, Sapienza University, Rome, Italy

3. University of Lucerne, Lucerne, Switzerland

4. Department of Urology, Indiana University School of Medicine, Indianapolis, IN

5. Division of Medical Oncology, Indiana University School of Medicine, Indianapolis, IN

6. Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL

7. Department of Urology, University of California, San Diego, CA

8. The University of Texas Southwestern, Dallas, TX

9. Department of Oncology, Comenius University, National Cancer Institute, Bratislava, Slovak Republic

10. Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA

11. Urologic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

12. Department of Urology, Uro-Oncology, Robot Assisted and Reconstructive Urologic Surgery, University of Cologne, Faculty of Medicine and University of Cologne, Cologne, Germany

13. Department of Urology, Medical University, Vienna, Austria

14. Section of Urology, Department of Surgery, University of Chicago Medical Center, Chicago, IL

15. Department of Urology, Mayo Clinic, Scottsdale, AZ

16. N.N. Blokhin Russian Cancer Research Center, Moscow, Russian Federation

17. Institut Gustave Roussy, Villejuif, France

18. Department of Urology, The Royal Marsden NHS Foundation Trust, London, United Kingdom

19. Institute of Cancer Research, London, United Kingdom

20. Department of Clinical Science, Intervention and Technology, Division of Urology, Karolinska Institutet, Stockholm, Sweden

21. Department of Urology, Skåne University Hospital, Malmö, Sweden

22. The Cancer Clinic, St Olavs University Hospital, Trondheim, Norway

23. Department of Clinical and Molecular Medicine, The Norwegian University of Science and Technology, Trondheim, Norway

24. University of Zurich, Zurich, Switzerland

Abstract

What is the role of pcRPLND in men with retroperitoneal vital cancer after first-line chemotherapy? This question arises because of the potential predictive value of miR371 in identifying residual cancer even before pcRPLND! @cdfankhauser shared data within a multicenter cohort study redefining future practice in the miR371 era.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3